Allarity Therapeutics Inc
Change company Symbol lookup
Select an option...
ALLR Allarity Therapeutics Inc
SIVB SVB Financial Group
LYLT Loyalty Ventures Inc
NMRD Nemaura Medical Inc
LOGI Logitech International SA
BIOC Biocept Inc
KT KT Corp
SVRA Savara Inc
KA Kineta Inc
IMNM Immunome Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company. The Company is engaged in targeting some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates together with its Drug Response Predictor (DRP) companion diagnostics in a precision medicine approach. The Company's products include dovitinib, stenoparib, and IXEMPRA (ixabepilone). The lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. The therapeutic candidate is stenoparib is a novel inhibitor of the key deoxyribonucleic acid (DNA) damage repair enzyme poly-ADP-ribose polymerase (PARP). The therapeutic candidate is IXEMPRA (ixabepilone) is a selective microtubule inhibitor. The DRP technology is a diagnostic platform that models human tumor biology and can help predict whether a cancer patient respond or not to a particular drug.

Closing Price
$0.1439
Day's Change
0.0389 (37.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.229
Day's Low
0.1301
Volume
(Heavy Day)
Volume:
83,434,571

10-day average volume:
8,156,624
83,434,571

Thinking about trading options or stock in Tesla, Raytheon, Verizon, Lowe's, or PayPal?

9:31 am ET January 3, 2023 (PR Newswire) Print

InvestorsObserverissues critical PriceWatch Alerts for TSLA, RTX, VZ, LOW, and PYPL.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=TSLA&prnumber=010320233

-- RTX: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=RTX&prnumber=010320233

-- VZ: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=VZ&prnumber=010320233

-- LOW: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=LOW&prnumber=010320233

-- PYPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=PYPL&prnumber=010320233

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG76621&sd=2023-01-03

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-tesla-raytheon-verizon-lowes-or-paypal-301712368.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG76621&Transmission_Id=202301030931PR_NEWS_USPR_____CG76621&DateId=20230103

comtex tracking

COMTEX_421825254/1005/2023-01-03T09:31:06

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.